(Q34024141)

30 July 2017

title

Hepatitis D virus: an update (English)

1 reference

30 July 2017

main subject

hepatitis delta virus

1 reference

1 reference

Stéphanie Pascarella

1

1 reference

30 July 2017

Francesco Negro

2

1 reference

30 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20880077

22 July 2024

publication date

29 September 2010

1 reference

full work available at URL

30 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1478-3231.2010.02320.x

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1478-3231.2010.02320.x

22 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

22 July 2024

1 reference

30 July 2017

volume

31

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

7-21

1 reference

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Eighth major clade for hepatitis delta virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Recombination of hepatitis D virus RNA sequences and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Chronic Hepatitis D Virus (HDV) Infection in Hepatitis B Virus Carrier Chimpanzees Experimentally Superinfected with HDV

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Hepatitis Delta Virus Infection and Labrea Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Reappearance of hepatitis D virus (HDV) replication in chronic hepatitis B virus carrier chimpanzees rechallenged with HDV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02320.X

Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

22 July 2024

Delta agent

3

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Structure, sequence and expression of the hepatitis delta (delta) viral genome

22 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The increasing prevalence of hepatitis delta virus (HDV) infection in South London

22 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Decrease in HDV endemicity in Italy.

22 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

22 July 2024

chronic hepatitis D

9

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis D virus infection--not a vanishing disease in Europe!

22 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Evolution of hepatitis delta virus RNA during chronic infection

22 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Sequence conservation and divergence of hepatitis delta virus RNA.

22 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome

22 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Heterogeneity and evolution rates of delta virus RNA sequences

22 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A genotype of hepatitis D virus that occurs in northern South America

22 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan

22 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease

22 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells

22 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D.

22 July 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Immunohistochemical differentiation of hepatitis D virus genotypes

22 July 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

22 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Delta-infection and suppression of hepatitis B virus replication in chronic HBsAg carriers.

22 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Patterns of hepatitis delta virus reinfection and disease in liver transplantation

22 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope.

22 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Delta hepatitis in homosexual men in the United States

22 July 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Serological response to the hepatitis delta virus in hepatitis D.

22 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Serum hepatitis delta virus RNA in patients with delta hepatitis and in liver graft recipients

22 July 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection

22 July 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Evaluation of hepatitis delta virus RNA levels during interferon therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay

22 July 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Detection of hepatitis D virus RNA in serum by a reverse transcription, polymerase chain reaction-based assay

22 July 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics

22 July 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

22 July 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, Using serum as the delta antigen source

22 July 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Serological diagnosis of acute delta hepatitis

22 July 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients

22 July 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The natural history of chronic delta hepatitis

22 July 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece

22 July 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

22 July 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection

22 July 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Natural history of chronic hepatitis B

22 July 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Changing pattern of chronic hepatitis D in Southern Europe

22 July 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

22 July 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Epidemiology and Long-Term Consequences of Hepatitis Delta Virus Infection in the Yucpa Indians of Venezuela

22 July 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Discovery of a novel point mutation changing the HDAg expression of a hepatitis delta virus isolate from Central African Republic

22 July 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus

22 July 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients

22 July 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D.

22 July 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Treatment of chronic hepatitis D with interferon alfa-2a

22 July 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.

22 July 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

22 July 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon alfa-2a

22 July 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

22 July 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

22 July 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Lamivudine for chronic delta hepatitis

22 July 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Famciclovir treatment of chronic delta hepatitis

22 July 2024

87

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

22 July 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

22 July 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes

22 July 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Levamisole and chronic delta hepatitis

22 July 2024

93

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A pilot study of thymosin-alpha 1 therapy for chronic hepatitis D

22 July 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

22 July 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action

22 July 2024

98

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration

22 July 2024

99

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

22 July 2024

100

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Structural basis of the oligomerization of hepatitis delta antigen

22 July 2024

103

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus

22 July 2024

105

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades

22 July 2024

108

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

22 July 2024

110

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Identification and characterization of a hepatitis delta virus RNA transcriptional promoter

22 July 2024

111

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Structure and replication of the genome of the hepatitis delta virus

22 July 2024

112

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage.

22 July 2024

113

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Crystal structure of a hepatitis delta virus ribozyme

22 July 2024

114

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Alternative processing of hepatitis delta virus antigenomic RNA transcripts

22 July 2024

117

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase

22 July 2024

119

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

22 July 2024

120

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A specific base transition occurs on replicating hepatitis delta virus RNA

22 July 2024

121

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus

22 July 2024

124

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Stimulation of RNA polymerase II elongation by hepatitis delta antigen

22 July 2024

126

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen

22 July 2024

127

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus.

22 July 2024

128

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Virus entry into animal cells

22 July 2024

129

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A novel chromosome region maintenance 1-independent nuclear export signal of the large form of hepatitis delta antigen that is required for the viral assembly

22 July 2024

130

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Identification of a prenylation site in delta virus large antigen

22 July 2024

131

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen.

22 July 2024

132

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity

22 July 2024

134

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues

22 July 2024

136

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly.

22 July 2024

137

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication

22 July 2024

139

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis

22 July 2024

140

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Modification of small hepatitis delta virus antigen by SUMO protein

22 July 2024

141

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Role of N Glycosylation of Hepatitis B Virus Envelope Proteins in Morphogenesis and Infectivity of Hepatitis Delta Virus

22 July 2024

142

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

22 July 2024

143

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition

22 July 2024

144

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Characterization of a hepatitis B and hepatitis delta virus receptor binding site

22 July 2024

145

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans

22 July 2024

146

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus

22 July 2024

147

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Assembly of endocytic machinery around individual influenza viruses during viral entry

22 July 2024

148

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Endocytosis by random initiation and stabilization of clathrin-coated pits

22 July 2024

149

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis

22 July 2024

150

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Large hepatitis delta antigen is a novel clathrin adaptor-like protein

22 July 2024

151

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus

22 July 2024

152

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus

22 July 2024

153

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome

22 July 2024

154

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates.

22 July 2024

155

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Characterization of the 5' ends for polyadenylated RNAs synthesized during the replication of hepatitis delta virus.

22 July 2024

156

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases

22 July 2024

157

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III.

22 July 2024

159

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A Replication Cycle for Viroids and Other Small Infectious RNA's

22 July 2024

161

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs

22 July 2024

162

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Identification of the functional regions required for hepatitis D virus replication and transcription by linker-scanning mutagenesis of viral genome

22 July 2024

163

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Stable expression of hepatitis delta virus antigen in a eukaryotic cell line.

22 July 2024

164

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen

22 July 2024

165

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease

22 July 2024

166

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells

22 July 2024

167

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity

22 July 2024

168

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A

22 July 2024

169

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The SV40 T antigen modulates CBP histone acetyltransferase activity

22 July 2024

170

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

22 July 2024

171

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Overexpression of clusterin in human hepatocellular carcinoma

22 July 2024

172

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Clusterin/apolipoprotein J in human aging and cancer

22 July 2024

173

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Deleterious effects of hepatitis delta virus replication on host cell proliferation

22 July 2024

174

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Development of a novel system to study hepatitis delta virus genome replication

22 July 2024

175

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus inhibits alpha interferon signaling

22 July 2024

176

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene.

22 July 2024

177

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Hepatitis delta virus large antigen sensitizes to TNF-alpha-induced NF-kappaB signaling

22 July 2024

178

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Changes in the proteome of Huh7 cells induced by transient expression of hepatitis D virus RNA and antigens

22 July 2024

179

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Proteome analysis of a human liver carcinoma cell line stably expressing hepatitis delta virus ribonucleoproteins

22 July 2024

180

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication

22 July 2024

181

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

The hepatitis delta virus RNA genome interacts with eEF1A1, p54(nrb), hnRNP-L, GAPDH and ASF/SF2.

22 July 2024

182

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Natural course and treatment of hepatitis D virus infection.

22 July 2024

183

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus

22 July 2024

184

1 reference

https://api.crossref.org/works/10.1111/J.1478-3231.2010.02320.X

22 July 2024

Identifiers

1 reference

30 July 2017

1 reference